Business Daily.
.
A+ R A-

Medidata’s Cloud-Based Platform Powers Next-Generation Immunotherapy Vaccine Trial in Australia

E-mail Print PDF
NEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Admedus Ltd (ASX:AHZ), a specialist healthcare company that delivers innovative medical technologies and devices, has adopted its industry-leading cloud technology. The Australian-based listed company is leveraging the Medidata Clinical Cloud® platform to bring speed, efficiencies and enhanced decision-making to its clinical develop

imageimage

Read more

Grow Your Business with Times Media
Business Daily Media